99 related articles for article (PubMed ID: 7614392)
1. In vivo effect of a selective endothelin receptor antagonist, BQ-123, on renal function in cyclosporin A-treated rats.
Tanda K; Seki T; Kobayashi S; Kanagawa K; Chikaraishi T; Togashi M; Nonomura K; Koyanagi T
Int J Urol; 1994 Dec; 1(4):309-15. PubMed ID: 7614392
[TBL] [Abstract][Full Text] [Related]
2. Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction.
Kivlighn SD; Gabel RA; Siegl PK
Kidney Int; 1994 Jan; 45(1):131-6. PubMed ID: 8127001
[TBL] [Abstract][Full Text] [Related]
3. Effects of selective endothelin antagonists on the hemodynamic response to cyclosporin A.
Davis LS; Haleen SJ; Doherty AM; Cody WL; Keiser JA
J Am Soc Nephrol; 1994 Jan; 4(7):1448-54. PubMed ID: 8161726
[TBL] [Abstract][Full Text] [Related]
4. Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat.
Abassi ZA; Pieruzzi F; Nakhoul F; Keiser HR
Hypertension; 1996 May; 27(5):1140-8. PubMed ID: 8621208
[TBL] [Abstract][Full Text] [Related]
5. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065.
Warner TD; Allcock GH; Vane JR
Br J Pharmacol; 1994 May; 112(1):207-13. PubMed ID: 8032643
[TBL] [Abstract][Full Text] [Related]
6. Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats.
Kon V; Hunley TE; Fogo A
Transplantation; 1995 Jul; 60(1):89-95. PubMed ID: 7624949
[TBL] [Abstract][Full Text] [Related]
7. Urinary enzymes as biomarkers of renal injury in experimental nephrotoxicity of immunosuppressive drugs.
Burdmann EA; Andoh TF; Lindsley J; Russell J; Bennett WM; Porter G
Ren Fail; 1994; 16(1):161-8. PubMed ID: 7514309
[TBL] [Abstract][Full Text] [Related]
8. Effects of a selective endothelin A-receptor antagonist, BQ-123, in salt-loaded stroke-prone spontaneously hypertensive rats.
Okada M; Kobayashi M; Maruyama H; Takahashi R; Ikemoto F; Yano M; Nishikibe M
Clin Exp Pharmacol Physiol; 1995 Oct; 22(10):763-8. PubMed ID: 8575114
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats.
Mino N; Kobayashi M; Nakajima A; Amano H; Shimamoto K; Ishikawa K; Watanabe K; Nishikibe M; Yano M; Ikemoto F
Eur J Pharmacol; 1992 Oct; 221(1):77-83. PubMed ID: 1459192
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelinB receptor.
Tack I; Marin-Castano E; Bascands JL; Pecher C; Ader JL; Girolami JP
Br J Pharmacol; 1997 Jun; 121(3):433-40. PubMed ID: 9179384
[TBL] [Abstract][Full Text] [Related]
11. In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor.
Ihara M; Ishikawa K; Fukuroda T; Saeki T; Funabashi K; Fukami T; Suda H; Yano M
J Cardiovasc Pharmacol; 1992; 20 Suppl 12():S11-4. PubMed ID: 1282942
[TBL] [Abstract][Full Text] [Related]
12. Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.
Lanese DM; Conger JD
J Clin Invest; 1993 May; 91(5):2144-9. PubMed ID: 8486781
[TBL] [Abstract][Full Text] [Related]
13. Impaired response of the denervated kidney to endothelin receptor blockade in normotensive and spontaneously hypertensive rats.
Girchev R; Bäcker A; Markova P; Kramer HJ
Kidney Int; 2004 Mar; 65(3):982-9. PubMed ID: 14871418
[TBL] [Abstract][Full Text] [Related]
14. Experimental nephrotoxicity, hepatotoxicity and pharmacokinetics of cyclosporin G versus cyclosporin A.
Burdmann EA; Andoh TF; Rosen S; Lindsley J; Munar MY; Elzinga LW; Bennett WM
Kidney Int; 1994 Mar; 45(3):684-91. PubMed ID: 8196271
[TBL] [Abstract][Full Text] [Related]
15. Effects of BQ-123 on systemic and renal hemodynamic responses to endothelin-1 in the rat split hydronephrotic kidney.
Cavarape A; Bartoli E
J Hypertens; 1998 Oct; 16(10):1449-58. PubMed ID: 9814615
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
Gruber SA; Gallichio M; Rosano TG; Kaplan SS; Hughes SE; Urbauer DL; Singh TP; Lempert N; Conti DJ; Stein DS; Drusano G
J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
[TBL] [Abstract][Full Text] [Related]
17. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
Fujisaki K; Kubo M; Masuda K; Tokumoto M; Hirakawa M; Ikeda H; Matsui R; Matsuo D; Fukuda K; Kanai H; Hirakata H; Iida M
Clin Exp Nephrol; 2003 Dec; 7(4):279-83. PubMed ID: 14712357
[TBL] [Abstract][Full Text] [Related]
18. Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats.
Cavarape A; Endlich K; Feletto F; Parekh N; Bartoli E; Steinhausen M
Kidney Int; 1998 Apr; 53(4):963-9. PubMed ID: 9551405
[TBL] [Abstract][Full Text] [Related]
19. Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity.
Fogo A; Hellings SE; Inagami T; Kon V
Kidney Int; 1992 Sep; 42(3):770-4. PubMed ID: 1405355
[TBL] [Abstract][Full Text] [Related]
20. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
Pollock DM; Opgenorth TJ
Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
